September 17, 2009 — The US Food and Drug Administration (FDA)'s Arthritis Advisory Committee voted unanimously (12 to 0) yesterday to recommend approval of collagenase clostridium histolyticum ...
Arthrogryposis Multiplex Congenita (AMC) and congenital contractures constitute a group of clinically heterogeneous conditions defined by multiple joint contractures present at birth. These disorders ...
Arthrogryposis is when a baby has one or more permanently-extended joints, known as contracture, at birth. Arthrogryposis is often manageable and does not typically affect life expectancy. A ...
Keenova Therapeutics plc announced today that a new presentation related to Dupuytren's contracture (DC) and XIAFLEX ® ...
Arthrogryposis multiplex congenita (AMC) is a group of conditions that affect the joints and is present at birth. People with AMC have a reduced range of motion in certain joints. AMC first occurs in ...
MALVERN, Pa., March 24, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today that data related to the use of XIAFLEX® (collagenase clostridium histolyticum, or CCH) for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results